Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-030953

Options or other derivatives

  • Director acquired 23,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Greene Barry E Director 2022-05-19 Grant or award · Nonstatutory Stock Option (right to buy) +23,900 23,900 D: show line 1 in the form
Loading xslF345X03/doc4.xml…